Potentially fatal crisis after 177Lu-DOTATATE therapy for paraganglioma: a case report with review of literature
Endocrine Journal · 2025
DOI: 10.1507/endocrj.ej24-0713 ↗Kurz gefasst
Fallbericht in der Zeitschrift Endocrine Journal, 2025. Verfasst von Aoki Tobimatsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: Octreotide, Organometallic Compounds, Adrenal Gland Neoplasms, Paraganglioma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan.
- Department of Radiology, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan.
- Department of Adipose Management, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan.
Zitieren
APA
Tobimatsu, A., Mukai, K., Obata, Y., Isohashi, K., Miyashita, K., Fukuhara, A., Kato, H., & Shimomura, I. (2025). Potentially fatal crisis after 177Lu-DOTATATE therapy for paraganglioma: a case report with review of literature. Endocrine Journal. https://doi.org/10.1507/endocrj.ej24-0713
Vancouver
Tobimatsu A, Mukai K, Obata Y, Isohashi K, Miyashita K, Fukuhara A, et al. Potentially fatal crisis after 177Lu-DOTATATE therapy for paraganglioma: a case report with review of literature. Endocrine Journal. 2025. doi:10.1507/endocrj.ej24-0713
BibTeX
@article{Tobimatsu2025,
author = {Tobimatsu, Aoki and Mukai, Kosuke and Obata, Yoshinari and Isohashi, Kayako and Miyashita, Kazuyuki and Fukuhara, Atsunori and Kato, Hiroki and Shimomura, Iichiro},
title = {Potentially fatal crisis after 177Lu-DOTATATE therapy for paraganglioma: a case report with review of literature},
journal = {Endocrine Journal},
year = {2025},
doi = {10.1507/endocrj.ej24-0713}
}
EUVIMED